HomePHAT • NASDAQ
add
Phathom Pharmaceuticals Inc
Previous close
$10.96
Day range
$10.70 - $11.47
Year range
$2.21 - $18.31
Market cap
878.61M USD
Avg Volume
1.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 57.58M | 94.12% |
Operating expense | 55.86M | -34.48% |
Net income | -21.15M | 71.59% |
Net profit margin | -36.73 | 85.37% |
Earnings per share | -0.08 | 92.38% |
EBITDA | -5.80M | 90.21% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 129.97M | -56.28% |
Total assets | 259.15M | -31.50% |
Total liabilities | 697.32M | 10.35% |
Total equity | -438.17M | — |
Shares outstanding | 78.80M | — |
Price to book | -1.79 | — |
Return on assets | -5.93% | — |
Return on capital | -9.51% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -21.15M | 71.59% |
Cash from operations | -5.00M | 92.12% |
Cash from investing | -87.00K | -1,640.00% |
Cash from financing | -97.00K | -100.37% |
Net change in cash | -5.18M | 86.14% |
Free cash flow | 2.08M | 104.73% |
About
Founded
2018
Headquarters
Website
Employees
371
